𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon-α therapy in HBeAg-negative chronic hepatitis B: a long-term prospective study from north-western Greece

✍ Scribed by G. BALTAYIANNIS; K. KATSANOS; P. KARAYIANNIS; E. V. TSIANOS

Book ID
108604646
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
141 KB
Volume
24
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term outcomes of thymosin-α1 and in
Long-term outcomes of thymosin-α1 and interferon α-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B
✍ Murat Saruc; Nuri Ozden; Nurten Turkel; Semin Ayhan; Lynette M. Hock; Isil Tuzcu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 1 views

Hepatitis B e antibody (HbeAb) and hepatitis B virus (HBV) DNA positive chronic hepatitis is a clinical entity, distinct from classical hepatitis B e antigen (HbeAg) positive chronic hepatitis B. Our aim was to evaluate the long-term therapeutic efficacy of the combination of interferon alpha-2b and